
KMTS Stock Forecast & Price Target
KMTS Analyst Ratings
Bulls say
Kestra Medical Techs is well positioned for sustainable revenue growth and margin expansion with increasing market share, expanding market and salesforce, and new product updates combined with market acceptance.
Bears say
Kestra Medical Techs is expected to see continued market share gains and strong prescription volume trends driving growth in their Cardiac Recovery System platform, which features ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD). The company recently reported a F3Q beat with 58% y/y growth in ASSURE prescription volume and has raised their FY26 guide to $93M (+55% y/y). With ongoing expansion efforts and a comprehensive and developed system, Kestra Medical Techs is poised for success in the cardiovascular disease market.
This aggregate rating is based on analysts' research of Kestra Medical Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
KMTS Analyst Forecast & Price Prediction
Start investing in KMTS
Order type
Buy in
Order amount
Est. shares
0 shares